Funding for this research was provided by:
Geisinger Health System Foundation (SRC-075)
Pennsylvania Department of Health (#SAP 4100070267)
National Human Genome Research Institute (T32HG009495-01)
Received: 30 August 2018
Accepted: 15 April 2019
First Online: 3 May 2019
Change Date: 22 May 2019
Change Type: Correction
Change Details: Following publication of the original article , the authors reported that Fig. 1 was not correctly processed during the production process. The correct Fig. 1 is given below.
Ethics approval and consent to participate
: The DiscovEHR cohort enrolled individuals from MyCode, which uses written consent and has previously been described [CitationRef removed]. This study was deemed to be exempt, therefore no further consent was needed. Geisinger Medical Ethics Committee – Geisinger Health System IRB protocol. “Phenotype validation and Biomarker Discovery Protocol for gynecological disorders”. IRB number 2016–0119 was approved on 03/10/2016.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.